Retrospective Analysis to Describe Patient Profiles, Current Treatment Patterns and Economic Burden for Asthma Patients in UAE. A Descriptive Analysis of the Asthma Patient Population in the Emirate of Dubai With Respect to Healthcare Resource Utilization, Costs, and Asthma-related Treatment Pattern
NCT03963141 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40541
Last updated 2024-05-21
Summary
This Retrospective cohort study with an overall objective of to perform a descriptive analysis of the asthma patient population in the Emirate of Dubai with respect to healthcare resource utilization, costs, and asthma-related treatment patterns and outcome.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-08-31
- Primary Completion
- 2022-10-31
- Completion
- 2022-10-31
Countries
- United Arab Emirates
Study Locations
More Related Trials
-
Study in Patients With Asthma
NCT00215397 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD7594 Administered Once Daily by Inhalation in Asthmatic Subjects
NCT03622112 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Treatment Patterns of Severe Asthmatic Patients Across the Gulf Region - SevEos Study
NCT03387722 ·Status: COMPLETED
-
Study to Investigate Real Life Effectiveness of Symbicort Maintenance and Reliever Therapy in Asthma Patients Across Asia
NCT00939341 ·Status: COMPLETED ·Phase: PHASE4
-
Asthma Control, Quality of Life and Emotional Feelings in a Real Life Setting
NCT02640742 ·Status: COMPLETED
-
Estimating the Use of Resources and the Costs of Treating Patients With Asthma in the Autonomous Community of Valencia
NCT01114906 ·Status: COMPLETED
-
Comparative Study of the Efficacy of Biologics vs Usual Treatment on OCS Reduction for Severe Asthma Patients Using Health Insurance Claim Database
NCT05136547 ·Status: COMPLETED
-
Treatment Efficacy of Budesonide/Formoterol in Cough Variant Asthma and Typical Asthma Patients
NCT02934945 ·Status: UNKNOWN ·Phase: PHASE4
-
Study in Patients With Asthma
NCT00215358 ·Status: COMPLETED ·Phase: PHASE2
-
A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese Population
NCT06419413 ·Status: RECRUITING
-
Assessment Of Disease Pathology And Key Therapeutic Targets In Severe Asthma
NCT00327197 ·Status: TERMINATED ·Phase: PHASE1
-
Assessment of Asthma Control Level in Primary Care Setting in Malaysia
NCT03804632 ·Status: COMPLETED
-
A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients With Mild to Moderate Asthma
NCT02479412 ·Status: COMPLETED ·Phase: PHASE2
-
Asthma Patient Survey Study to Assess Asthma Effect and Medication in Finland
NCT00681382 ·Status: COMPLETED
-
Study in Patients With Asthma
NCT00215371 ·Status: COMPLETED ·Phase: PHASE2
-
Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy
NCT00319306 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical& Demographic Profiles of patIents With unControllEd Asthma in Russia: Multi-center oBsErvational ReGistry Study
NCT06521229 ·Status: RECRUITING
-
Effectiveness of Pharmacist Interventions in Difficult Asthma
NCT02363192 ·Status: COMPLETED ·Phase: NA
-
REALL: A Retrospective Observational Study to Compare the Effectiveness and Cost-Effectiveness Between Different Step-3 Asthma Treatment Strategies
NCT00628563 ·Status: COMPLETED
-
Study in Patients With Asthma
NCT00215410 ·Status: COMPLETED ·Phase: PHASE2
-
A Study for the Assessment of the Words Used by Patients and Physicians to Express Asthma Symptoms
NCT00986219 ·Status: COMPLETED
-
Efficacy of Sublingual Versus Subcutaneous Allergen Immunotherapy in Patients With Bronchial Asthma
NCT05786638 ·Status: COMPLETED ·Phase: NA
-
Asthma in Children
NCT01286532 ·Status: COMPLETED
-
The Economic Burden of Asthma in Canada
NCT03243110 ·Status: COMPLETED
-
Characterisation of Patients With Severe Asthma in Primary and Secondary Care Settings in Europe Reported to be Eligible for Biological Therapy
NCT03629782 ·Status: COMPLETED